J. Haigh

发表

A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis

R. Penn, J. Tonn, E. Malta, 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

Can benzodiazepines be classified by characterising their anticonvulsant tolerance-inducing potential?

M. Feely, J. Gent, J. Haigh, 1988, European journal of pharmacology.

Poor Compliance Is a Major Factor in Unstable Outpatient Control of Anticoagulant Therapy

S. Kumar, M. Feely, L. Rhodes, 1989, Thrombosis and Haemostasis.

Recent developments in the pharmacotherapy of major neurological dysfunction

C. Marsden, M. Traub, J. Haigh, 1992 .

Tolerance to the anticonvulsant effect of benzodiazepines.

M. Feely, J. Haigh, 1988, Trends in pharmacological sciences.

Indirect coupling of calcium transport in chromaffin granule ghosts to the proton pump.

J. Phillips, J. Haigh, 1993, Neuroreport.

Free concentrations of sodium, potassium and calcium in chromaffin granules.

J. Phillips, J. Haigh, R. Parris, 1989, The Biochemical journal.

The effects of simvastatin and pravastatin on objective and subjective measures of nocturnal sleep: a comparison of two structurally different HMG CoA reductase inhibitors in patients with primary moderate hypercholesterolaemia.

G. Block, P. Kvidal, J. Haigh, 1993, British journal of clinical pharmacology.

The induction of ret by Wnt-1 in PC12 cells is atypically dependent on continual Wnt-1 expression.

B. Howard, K. Steger, J. Haigh, 1996, Oncogene.

Acetylcholine active transport by rat brain synaptic vesicles.

S. Parsons, J. Haigh, K. Noremberg, 1994, Neuroreport.

RO 16-6028, a benzodiazepine receptor partial agonist, does not exhibit anticonvulsant tolerance in mice.

M. Feely, J. Haigh, 1988, European journal of pharmacology.

Effect of warfarin on plasma concentrations of vitamin K dependent coagulation factors in patients with stable control and monitored compliance

S. Kumar, M. Feely, D. Joanes, 1990, British journal of haematology.

Tolerance to the anticonvulsant effect of clonazepam in mice: no concurrent change in plasma concentration

M. Feely, J. Gent, J. Haigh, 1986, The Journal of pharmacy and pharmacology.

Benzodiazepine cross-tolerance in mice extends to sodium valproate.

M. Feely, J. Gent, J. Haigh, 1986, European journal of pharmacology.

Chapter 22 MEDICAL DIAGNOSTICS

J. R. Barr, R. K. Gordon, G. Platoff, 2009 .

Clinical Detection of Exposure to Chemical Warfare Agents *

J. R. Barr, R. K. Gordon, B. Lukey, 2019, Chemical Warfare Agents.

Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.

P. Aisen, R. K. Gordon, B. P. Doctor, 2005, Chemico-biological interactions.

Plasma concentrations of clobazam and its N‐desmethyl metabolite; protection against pentetrazol‐induced convulsions in mice

R. Calvert, J. Gent, J. Haigh, 1984, The Journal of pharmacy and pharmacology.

Differences between the tolerance characteristics of two anticonvulsant benzodiazepines.

M. Feely, J. Gent, J. Haigh, 1985, Life sciences.

N-desmethylclobazam: a possible alternative to clobazam in the treatment of refractory epilepsy?

T. Pullar, M. Feely, J. Gent, 1987, British journal of clinical pharmacology.

A sodium/proton antiporter in chromaffin-granule membranes.

J. Phillips, J. Haigh, 1989, Biochemical Journal.

Lipids and platelet function in runners.

E. Lea, J. Haigh, R. Pinn, 1988, British journal of sports medicine.

Advantages of the WRAIR whole blood cholinesterase assay: comparative analysis to the micro-Ellman, Test-mate ChE, and Michel (DeltapH) assays.

R. K. Gordon, B. P. Doctor, Richard K Gordon, 2008, Chemico-biological interactions.

Inhibition of guinea pig hemi-diaphragm acetylcholinesterase activity by pyridostigmine bromide and protection against soman toxicity.

R. K. Gordon, B. P. Doctor, M. Adler, 2005, Chemico-Biological Interactions.

Pharmacokinetics of N-desmethylclobazam in healthy volunteers and patients with epilepsy.

T. Pullar, M. Feely, J. Haigh, 1987, British journal of clinical pharmacology.

The effect of cimetidine on the single dose pharmacokinetics of oral clobazam and N-desmethylclobazam.

T. Pullar, M. Feely, J. Haigh, 1987, British journal of clinical pharmacology.

Development of tolerance to the anticonvulsant effects of clobazam.

J. Gent, J. Haigh, 1983, European journal of pharmacology.

Scopolamine and benzodiazepine models of dementia: cross-reversals by Ro 15-1788 and physostigmine

G. Preston, M. Traub, C. Lines, 2004, Psychopharmacology.

Comparison of effects on sleep of lovastatin and pravastatin in hypercholesterolemia.

T. Strandberg, M. Partinen, T. Miettinen, 1994, The American journal of cardiology.

Differential expression of transporters for norepinephrine and glutamate in wild type, variant, and WNT1-expressing PC12 cells.

A. Varpetian, K. Houben, B. Howard, 1993, The Journal of biological chemistry.

The effect of allopurinol on the steady-state pharmacokinetics of indomethacin.

T. Pullar, H. Bird, J. Dixon, 1988, British journal of clinical pharmacology.

Protection by pyridostigmine bromide of marmoset hemi-diaphragm acetylcholinesterase activity after soman exposure.

R. K. Gordon, M. Adler, Patrick F. Desmond, 2010, Chemico-biological interactions.